NSD2 and metabolic dysfunction-associated steatohepatitis: NSD2 directly regulates the transcriptional activation of Ern1 through the demethylation of histone H3 at lysine 36 (H3K36me2), resulting in the activation of the ERN1–JNK axis, exacerbation of intestinal barrier impairment, and subsequent promotion of NASH progression.